Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach
Open accessThe DOI matches its Crossref record; 180 of the 186 references it cites were found in a registry or an index, and 5 are not checked yet; 101 of the 225 sources its claims cite were checked for support.
Abstract
Pathological narcissism (PN) is a complex, treatment-resistant disorder characterized by unstable self-esteem that fluctuates between grandiosity and vulnerability, complicating the formation of a stable self-image. With few empirically supported therapies, treatment has traditionally relied on long-term psychoanalytic approaches, but these often face high attrition. Recent research suggests a potential therapeutic synergy between psychedelics and psychoanalytic therapy, offering a novel approach to addressing entrenched personality structures. Studies on MDMA (3,4-methylenedioxymethamphetamine), a compound known for enhancing empathy, trust, and social interactions, demonstrate potential to reopen critical periods for social learning in adults, offering the possibility of therapeutic benefits for conditions with core issues in relatedness, such as PN. MDMA promotes psychological flexibility and openness, allowing for deeper self-exploration and strengthening the observing ego, considered in psychoanalytic therapy to be an essential component for recognizing and modifying maladaptive patterns. By reducing fear-based avoidance in the brain, MDMA facilitates access to unconscious emotions, helping individuals process overwhelming feelings linked to early relational trauma commonly seen in PN. Additionally, MDMA’s capacity to enhance compassion and empathy can fortify the therapeutic alliance, increasing its potential to facilitate relational change. This paper presents an MDMA-assisted therapy (MDMA-AT) tailored for narcissistic patients which is currently being conducted as an investigator-initiated trial (IIT). It explores the model’s theoretical foundations, mechanisms of change, treatment framework, and clinical challenges. Combining MDMA with an evidence-based depth therapy like psychoanalytic psychotherapy may offer an innovative treatment for conditions associated with attachment and developmental trauma, particularly personality disorders. While the role of psychotherapy in psychedelic treatments remains a topic of debate, with some proposing psychedelics be administered without psychotherapy, we assert that individuals with early relational trauma stand the most to gain from an integrated psychedelic-assisted therapy (PAT) model, where MDMA enhances the therapeutic alliance and emotional openness while psychoanalytic interventions provide the structure for lasting change. Copyright © 2025 Albert and Back.
Verified 2026-11-19 · 5 references not checked yet
Overview
CoChat Summary
## TL;DR
This paper is a hypothesis/theoretical article proposing a psychoanalytically informed MDMA-assisted therapy (MDMA-AT) for pathological narcissism (PN), and it situates the model in an ongoing investigator-initiated pilot study. The authors argue that MDMA’s prosocial and fear-reducing effects may complement psychoanalytic psychotherapy by improving reflective functioning, emotion regulation, agency, and the therapeutic alliance.
## Key findings
- The paper frames PN as a treatment-resistant condition with high dropout in conventional long-term psychoanalytic treatment and no strong empirical evidence for pharmacotherapy; it notes dropout rates of 63–64% in psychodynamic therapies.
- It reports that PN prevalence estimates reach up to 6.2% in the U.S. general population, with higher rates among men (7.7%) than women (4.8%), and that prevalence in clinical populations may be up to 20%.
- The authors cite prior psychedelic findings relevant to personality change, including one study in which ayahuasca was associated with modest reductions in entitlement and increases in leadership authority up to three months post-retreat, though effect sizes were small and results mixed.
- The paper states that the proposed MDMA-AT is being evaluated in an investigator-initiated pilot study titled “A Pilot Study of MDMA-Assisted Therapy for the Treatment of Pathological Narcissism” (NCT06565494), and that this will be the first known clinical trial to integrate psychoanalytic techniques with psychedelic medicine.
## Methods
- This is a theoretical/hypothesis paper that proposes a treatment model rather than reporting completed efficacy results; it is built from literature on PN, psychoanalytic therapy, and MDMA/PAT.
- The paper describes an ongoing investigator-initiated pilot study at the University of Washington IRB with participants aged 18–64 who meet DSM-5 Section III criteria for PN or narcissistic personality disorder and are already in outpatient psychotherapy.
- The pilot protocol uses a three-phase PAT structure (Preparation, Medicine, Integration), with three Preparation sessions (60–90 minutes each), three MDMA sessions spaced about four weeks apart, and three Integration sessions after each MDMA session; primary outcome is the Brief Pathological Narcissism Inventory (B-PNI), with safety monitoring including C-SSRS and SPSI.
## Limitations
- The paper explicitly notes that the combined potential of psychoanalytic therapy and MDMA-assisted therapy for PN remains unexplored, and that the pilot study is intended to provide only preliminary insights into safety and efficacy.
- It states that the field lacks clinical trials exploring psychoanalytic approaches to PAT, so the model is largely theoretical at this stage.
- Evident from the text: the article does not report completed trial outcomes, so its claims about benefit are hypothetical and not yet empirically validated in PN.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
73 Valid · 8 Not valid · 56 Not checked · 32 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Strongly associated with a history of child maltreatment, particularly neglect (47–49)”
§ Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach > Pathological narcissism across development, neurobiology, and treatment
What the sources say
- Not checked — no full text of the sourcecites [47] Gao S Yu D Assink M Chan KL Zhang L Meng X. The association between child maltreatment and pathological narcissism: A three-level meta-analytic review. Trauma Violence Abuse. (2024) 25: 275–90. doi: 10.1177/15248380221147559 36651026 source
- Supportedcites [48] Ross AG Giri S Anyasodor AE Mahmood S Astawesegn FH Huda MM. Adverse childhood experiences leading to narcissistic personality disorder: a case report. BMC Psychiatry. (2024) 24: 842. doi: 10.1186/s12888-024-06307-9 39578751 PMC11583436 source
The Background section (“Association of ACEs and NPD”) reports a significant association between adverse childhood experiences and pathological narcissism. It also says narcissistic traits were more common among people who experienced neglect than among those who experienced physical abuse. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [49] Bertele N Talmon A Gross JJ. Childhood maltreatment and narcissism: the mediating role of dissociation. J Interpers Violence. (2022) 37(11-12): NP9525–47. doi: 10.1177/0886260520984404 33356780 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Neuroimaging studies indicate that individuals with high narcissistic traits exhibit reduced grey matter volume in the anterior cingulate cortex (ACC), medial prefrontal cortex (mPFC), and dorsolateral prefrontal cortex (dPFC) - regions critical for self-awareness, emotion regulation, and social cognition (58, 95).”
§ Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach > A psychoanalytically informed MDMA-assisted therapy: a novel approach > Theoretical foundations
What the sources say
- Not checked — no full text of the sourcecites [58] Schulze L Dziobek I Vater A Heekeren HR Bajbouj M Renneberg B. Gray matter abnormalities in patients with narcissistic personality disorder. J Psychiatr Res. (2013) 47: 1363–9. doi: 10.1016/j.jpsychires.2013.05.017 23777939 source
- Partly supportedcites [95] Jauk E Kanske P. Can neuroscience help to understand narcissism? A systematic review of an emerging field. Personal Neurosci. (2021) 4: e3. doi: 10.1017/pen.2021.1 34124536 PMC8170532 sourceExperimental — accuracy not yet measured
The Structural imaging studies section reports lower gray matter volume in the medial prefrontal/anterior cingulate region in patients with narcissistic personality disorder, and lower dorsolateral prefrontal cortical volume associated with pathological narcissism in a nonclinical sample (page numbers unavailable). The claim combines findings from different populations and treats cortical volume as gray matter volume, so it overstates what the review establishes for individuals with high narcissistic traits generally. (LLM, conf=0.86)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“While the exact mechanisms of action remain unclear, and despite study limitations including small sample sizes and challenges in maintaining blindness in placebo-controlled trials (36), these preliminary findings support the potential use of psychedelics in personality disorder treatment (18, 25, 37, 38).”
§ Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach > Introduction
What the sources say
- Not checked — no full text of the sourcecites [18] Zeifman RJ Wagner AC. Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder. J Contextual Behav Sci. (2020) 15: 1– 11. doi: 10.1016/j.jcbs.2019.11.001 source
- Supportedcites [25] Iliff J Moslehi S. Could psychedelics treat personality disorders? J Addict Sci. (2022) 8(1): 10–9. doi: 10.17756/jas.2022-057 source
The Abstract (page not available) reviews historical findings on psychedelics for personality disturbance and disorders and concludes that further investigation, including preliminary trials, is indicated despite significant risks and difficulties. The discussion of historical studies reports possible benefits while emphasizing their limitations, consistent with the claim's cautious description of treatment potential. (LLM, conf=0.90)
- Partly supportedcites [37] Inouye AM Wolfgang AS Philhower LT. MDMA-assisted therapy for borderline personality disorder. J Psychedelic Stud. (2023) 7: 227–37. doi: 10.1556/2054.2023.00196 sourceExperimental — accuracy not yet measured
The Conclusion (page unavailable) calls for further research into MDMA-assisted therapy for borderline personality disorder, which supports considering its potential. But the Limitations section says the findings are four clinicians’ hypotheses, not treatment results in patients; the paper does not establish potential use across psychedelics or personality disorders generally. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [38] Traynor JM Roberts DE Ross S Zeifman R Choi-Kain L. MDMA-assisted psychotherapy for borderline personality disorder. Focus (Am Psychiatr Publ). (2022) 20: 358–67. doi: 10.1176/appi.focus.20220056 PMC10187385 37200873 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Despite these structural differences, individuals with PN display heightened anterior insula (AI) and dorsal ACC (dACC) activity in response to social exclusion, indicating increased rejection sensitivity despite an outward appearance of emotional detachment (96).”
§ Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach > A psychoanalytically informed MDMA-assisted therapy: a novel approach > Theoretical foundations
What the sources say
- Partly supportedcites [96] Cascio CN Konrath SH Falk EB. Narcissists’ social pain seen only in the brain. Soc Cognit Affect Neurosci. (2015) 10(3): 335–41. doi: 10.1093/scan/nsu072 PMC4350489 24860084 sourceExperimental — accuracy not yet measured
The Region of interest analyses report that higher Narcissistic Personality Inventory scores correlated with greater anterior insula and dACC activation during exclusion; the Conclusion interprets this as possible increased sensitivity to exclusion. But the study measured narcissistic traits in adolescent males, not pathological narcissism (PN) specifically. Its Results found no corresponding association with self-reported distress, which is consistent with the contrast in the claim, but it did not directly observe outward emotional detachment. Page numbers were unavailable in our copy. (LLM, conf=0.88)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This window represents the opening of a critical learning period, that promotes plasticity in thought, emotion, behavior, and interpersonal relationships that lasts for approximately two weeks after an MDMA session (87).”
§ Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach > A psychoanalytically informed MDMA-assisted therapy: a novel approach > Theoretical foundations
What the sources say
- Partly supportedcites [87] Nardou R Sawyer E Song YJ Wilkinson M Padovan-Hernandez Y de Deus JL. Psychedelics reopen the social reward learning critical period. Nature. (2023) 618: 790–8. doi: 10.1038/s41586-023-06204-3 PMC10284704 37316665 sourceExperimental — accuracy not yet measured
The Main section says MDMA reopens a critical period for social reward learning, and ‘Duration of the psychedelic open state’ says the MDMA-induced reopening lasts two weeks. But the two-week finding concerns social reward learning in mice, not a demonstrated therapeutic window after a human MDMA-assisted therapy session; the paper also does not establish plasticity across all the listed domains of thought, emotion, behavior, and interpersonal relationships. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
58 more claims · 19 with their cited sources checked
Create a free account to see all 169 claims and to verify the 7 references still open.
- Probably not a substantial claim. 35
- It may state two separate claims as one. 84
Citations
Cites
The Standard Edition of the Complete Psychological Works of Sigmund Freud
Freud, S. (1953) · Cited by 17,730
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Cognitive-Behavioral Treatment of Borderline Personality Disorder
Cary, G. L. (1994) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1994.48.1.155 · Cited by 6,283
Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111704 · Cited by 5,157
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Winnicott, D. W. (2018) · Routledge eBooks · doi:10.4324/9780429482410 · Cited by 3,675
Borderline Conditions and Pathological Narcissism
Kernberg, O. F. (1995) · doi:10.5040/9798216436638 · Cited by 2,862
Relation between working alliance and outcome in psychotherapy: A meta-analysis
Horvath, A. O., & Symonds, B. D. (1991) · Journal of Counseling Psychology · doi:10.1037/0022-0167.38.2.139 · Cited by 2,673
Alliance in individual psychotherapy
Horvath, A. O., Del Re, A. C., Flückiger, C., & Symonds, D. (2011) · Psychotherapy · doi:10.1037/a0022186 · Cited by 2,072 · cited 1×
“The therapeutic alliance is a well-established predictor of positive treatment outcomes across a range of psychotherapeutic modalities (158 – 160), including psychoanalytic psychotherapy (161) and the treatment of personality disorders such as PN (162, 163).”
The alliance in adult psychotherapy: A meta-analytic synthesis
Flückiger, C., Del Re, A. C., Wampold, B. E., & Horvath, A. O. (2018) · Psychotherapy · doi:10.1037/pst0000172 · Cited by 1,763 · cited 1×
“Since the therapeutic alliance is a key predictor of change, therapists must stay attuned to relational shifts and address ruptures as they arise (159).”
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Affect regulation, mentalization, and the development of the self
Koh, E. (2004) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01308.x · Cited by 1,702
The efficacy of psychodynamic psychotherapy
Shedler, J. (2010) · American Psychologist · doi:10.1037/a0018378 · Cited by 1,452
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207 · cited 1×
“MDMA ’ s in fl uence on the salience network also facilitates a shift toward positive emotional experiences, reinforcing affective learning and emotional regulation (93, 94).”
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180
Pathological narcissism and narcissistic personality disorder
Pincus, A. L., & Lukowitsky, M. R. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131215 · Cited by 1,082 · cited 2×
“The term PN has been increasingly adopted over NPD, as it encompasses both grandiose and vulnerable expressions of narcissistic dysfunction (42).”
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G., M., Garas, W., Paleos, C., Gorman, I., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01336-3 · Cited by 1,004
Forms and Transformations of Narcissism
Kohut, H. (1966) · Journal of the American Psychoanalytic Association · doi:10.1177/000306516601400201 · Cited by 912 · cited 1×
“Bowlby (143) identi fi ed mourning as crucial for adaptation, while Kohut (144) linked narcissistic injuries to unmet childhood needs, necessitating the grieving of idealized self and other representations.”
MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852
Childhood Maltreatment Increases Risk for Personality Disorders During Early Adulthood
Johnson, J. G., Cohen, P., Brown, J., Smailes, E. M., & Bernstein, D. P. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.7.600 · Cited by 839 · cited 1×
“…of personality disorders remains uncertain, research suggests they result from a complex interaction between genetic, environmental, epigenetic, and developmental factors, with childhood mistreatment strongly linked to subsequent impairments in both intrapersonal and interpersonal functioning (16).”
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain
Gulati, M., Levy, P. D., Mukherjee, D., Amsterdam, E., Bhatt, D. L., Birtcher, K. K., Blankstein, R., Boyd, J., Bullock-Palmer, R. P., Conejo, T., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.07.053 · Cited by 824
Bowlby, J. (1961) · PubMed · Cited by 759
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
(1978) · The International Journal of Psychoanalysis · Cited by 684
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674
Psychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754710 · Cited by 657
Classification, assessment, prevalence, and effect of personality disorder
Tyrer, P., Reed, G. M., & Crawford, M. J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61995-4 · Cited by 656
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Kalin, N. H., McDonald, W. M., & and the Work Group on Biomarkers and Novel Treatments, A. D. O. T. A. P. A. C. O. R. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19010035 · Cited by 649 · cited 1×
“Moreover, comorbid conditions such as suicidality and substance use disorders further complicate research efforts (13, 18, 20, 21).”
The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas
Carhart-Harris, R. L., & Friston, K. J. (2010) · Brain · doi:10.1093/brain/awq010 · Cited by 574
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Vollenweider, F. X., & Preller, K. H. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0367-2 · Cited by 570 · cited 1×
“Additionally, MDMA reduces activity in the Default Mode Network (DMN), potentially loosening rigid self-referential thinking patterns (92).”
Remembering, Repeating, and Working Through
Felleman, S. (2014) · Film Trilogies · doi:10.1057/9780230371972.0019 · Cited by 537
Kliem, S., Kröger, C., & Kosfelder, J. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0021015 · Cited by 474
MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial
Mitchell, J. M., Ot’alora G., M., van der Kolk, B., Shannon, S., Bogenschutz, M., Gelfand, Y., Paleos, C., Nicholas, C. R., Quevedo, S., Balliett, B., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02565-4 · Cited by 455
Therapeutic alliance as a mediator of change: A systematic review and evaluation of research
Baier, A. L., Kline, A. C., & Feeny, N. C. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101921 · Cited by 441 · cited 15×
“Emerging research supports the safety and ef fi cacy of psychedelic-assisted therapy (PAT) when administered in a controlled clinical environment (1, 2) for several treatment-resistant psychiatric disorders including depression (3 – 5), post-traumatic stress disorder (PTSD) (6, 7), substance use disorders (8, 9), socia…”
InfluentialGender differences in the subjective effects of MDMA
Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001) · Psychopharmacology · doi:10.1007/s002130000648 · Cited by 360
Psychedelics reopen the social reward learning critical period
Nardou, R., Sawyer, E., Song, Y. J., Wilkinson, M., Padovan-Hernandez, Y., de Deus, J. L., Wright, N., Lama, C., Faltin, S., Goff, L. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06204-3 · Cited by 358
MDMA enhances emotional empathy and prosocial behavior
Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst161 · Cited by 356 · cited 2×
“Kuypers (157) and Hysek et al. (81) found that MDMA enhances self-compassion and empathy and facilitates deeper self-re fl ection and interpersonal engagement, which may promote self-ef fi cacy in these patients.”
Blagys, M. D., & Hilsenroth, M. J. (2000) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.7.2.167 · Cited by 355
Zeigler‐Hill, V. (2006) · Journal of Personality · doi:10.1111/j.1467-6494.2005.00371.x · Cited by 350 · cited 1×
“Empirical evidence supports this conceptualization, demonstrating that narcissistic individuals exhibit high explicit but fragile implicit self-esteem, contributing to self-esteem instability and driving reliance on maladaptive self-enhancement strategies (57).”
[The theory of the parent-infant relationship].
Dw, W. (1961) · PubMed · Cited by 338
Stinson, F. S., Dawson, D. A., Golstein, R. B., Chou, P., Huang, B., Smith, S. M., Ruan, W. J., Pulay, A. J., Saha, T. D., Pickering, R. P., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0701 · Cited by 337
Comparing the process in psychodynamic and cognitive-behavioral therapies.
Jones, E. E., & Pulos, S. M. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.2.306 · Cited by 301
Psychodynamic Diagnostic Manual
Gordon, R. M. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0722 · Cited by 296
The paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293
Borderline Conditions and Pathological Narcissism
Frances, A. (1976) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1976.30.2.332 · Cited by 288
The Mentalization-Focused Approach to Self Pathology
Fonagy, P., & Target, M. (2006) · Journal of Personality Disorders · doi:10.1521/pedi.2006.20.6.544 · Cited by 273 · cited 1×
“Given that mentalization de fi cits contribute to personality pathology (141), investigation is warranted to assess MDMA ’ s role in enhancing re fl ective functioning in PN.”
Narcissistic Personality Disorder: Diagnostic and clinical challenges
Caligor, E., Levy, K. N., & Yeomans, F. E. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14060723 · Cited by 271
Narcissistic grandiosity and narcissistic vulnerability in psychotherapy.
Pincus, A. L., Cain, N. M., & Wright, A. G. C. (2014) · Personality Disorders: Theory, Research, and Treatment · doi:10.1037/per0000031 · Cited by 267 · cited 2×
“During these crises, symptoms of narcissistic vulnerability are most prominent, including acute suicidality, anhedonic depression, and anxiety (54, 69).”
Effects of psilocybin therapy on personality structure
Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart‐Harris, R. L. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12904 · Cited by 267
Psychedelics and connectedness
Carhart-Harris, R. L., Erritzoe, D., Haijen, E., Kaelen, M., & Watts, R. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4701-y · Cited by 265 · cited 1×
“However, researchers have recently suggested psychedelics as potential treatment based on evidence that psychedelic therapy can change patterns of cognitive-affective rigidity, emotion dysregulation, and interpersonal dysfunction (31, 32).”
The Personality Diagnostic Questionnaire-4 (PDQ-4).
Bagby, R. M., & Farvolden, P. (2004) · Cited by 260
Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression
Murphy, R., Kettner, H., Zeifman, R., Giribaldi, B., Kartner, L., Martell, J., Read, T., Murphy-Beiner, A., Baker-Jones, M., Nutt, D., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.788155 · Cited by 250 · cited 1×
“Integrating MDMA-AT with psychoanalytic principles may further establish the therapeutic relationship as a corrective emotional experience, fostering meaningful psychological change in individuals with PN (170, 171).”
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Holze, F., Vizeli, P., Müller, F., Ley, L., Duerig, R., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0569-3 · Cited by 247
Steinert, C., Munder, T., Rabung, S., Hoyer, J., & Leichsenring, F. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17010057 · Cited by 244
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Schenberg, E. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00733 · Cited by 240
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
Mithoefer, M. C., Grob, C. S., & Brewerton, T. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00576-3 · Cited by 239
Dumont, G. J. H., Sweep, F. C. G. J., van der Steen, R., Hermsen, R., Donders, A. R. T., Touw, D. J., van Gerven, J. M. A., Buitelaar, J. K., & Verkes, R. J. (2009) · Social Neuroscience · doi:10.1080/17470910802649470 · Cited by 238
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Personality Diagnostic Questionnaire-4+
Hyler, S. E. (2012) · PsycTESTS Dataset · doi:10.1037/t07759-000 · Cited by 232
Effects of MDMA on sociability and neural response to social threat and social reward
Bedi, G., Phan, K. L., Angstadt, M., & de Wit, H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1635-z · Cited by 206 · cited 3×
“MDMA also appears to modulate fear responses by reducing activity in the amygdala, decreasing reactions to socially threatening stimuli while enhancing responses to socially rewarding signals - an effect that may in fl uence emotional memory processing (89).”
InfluentialThe Rooting of the Mind in the Body: New Links Between Attachment Theory and Psychoanalytic Thought
Fonagy, P., & Target, M. (2007) · Journal of the American Psychoanalytic Association · doi:10.1177/00030651070550020501 · Cited by 204 · cited 1×
“These projections are largely shaped by early childhood attachment experiences and interpersonal patterns, re fl ecting deeply ingrained relational templates (14, 115, 126).”
Development of a brief version of the Pathological Narcissism Inventory.
Schoenleber, M., Roche, M. J., Wetzel, E., Pincus, A. L., & Roberts, B. W. (2015) · Psychological Assessment · doi:10.1037/pas0000158 · Cited by 199
Must Psilocybin Always “Assist Psychotherapy”?
Goodwin, G. M., Malievskaia, E., Fonzo, G. A., & Nemeroff, C. B. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20221043 · Cited by 189
Treatment adherence: The importance of therapist flexibility in relation to therapy outcomes.
Owen, J., & Hilsenroth, M. J. (2014) · Journal of Counseling Psychology · doi:10.1037/a0035753 · Cited by 177
Sloshower, J., Guss, J., Krause, R., Wallace, R. M., Williams, M. T., Reed, S., & Skinta, M. D. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.002 · Cited by 171
Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
Cavarra, M., Falzone, A., Ramaekers, J. G., Kuypers, K. P. C., & Mento, C. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.887255 · Cited by 171 · cited 3×
“Conversely, proponents of a synergistic approach contend that psychedelics enhance therapeutic outcomes when combined with psychotherapy (106 – 109).”
Kamilar-Britt, P., & Bedi, G. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.016 · Cited by 163
Semerari, A., Carcione, A., Dimaggio, G., Nicolò, G., & Procacci, M. (2007) · Psychotherapy Research · doi:10.1080/10503300500536953 · Cited by 163
The Neurobiological Underpinnings of Psychoanalytic Theory and Therapy
Solms, M. L. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00294 · Cited by 163
Wagner, M. T., Mithoefer, M. C., Mithoefer, A. T., MacAulay, R. K., Jerome, L., Yazar-Klosinski, B., & Doblin, R. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711712 · Cited by 160
Earp (2019) · doi:10.1098/rsos.190161 · Cited by 160
The Therapeutic Alliance in the Treatment of Personality Disorders
BENDER, D. S. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200503000-00002 · Cited by 155 · cited 2×
“Thus, the therapeutic relationship serves both as a mechanism of change - allowing patients to process emotional experiences in real time - and as a treatment goal, resulting in more adaptive relational patterns (164, 165).”
Differential effects of MDMA and methylphenidate on social cognition
Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B. B., & Liechti, M. E. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114542454 · Cited by 155
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis
Ko, K., Kopra, E. I., Cleare, A. J., & Rucker, J. J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.168 · Cited by 150 · cited 1×
“…therapy (PAT) when administered in a controlled clinical environment (1, 2) for several treatment-resistant psychiatric disorders including depression (3 – 5), post-traumatic stress disorder (PTSD) (6, 7), substance use disorders (8, 9), social anxiety (10), and obsessive-compulsive disorder (11).”
Effects of MDMA and intranasal oxytocin on social and emotional processing
Kirkpatrick, M. G., Lee, R., Wardle, M. C., Jacob, S., & de Wit, H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.12 · Cited by 143 · cited 3×
“MDMA ’ s softening of rigid self-protective mechanisms reduces interpersonal defensiveness, and increases sensitivity to emotional and relational dynamics, allowing for deeper engagement in the therapeutic process (88, 100, 102).”
The theory of the parent-infant relationship.
Winnicott, D. W. (2016) · The Collected Works of D. W. Winnicott · doi:10.1093/med:psych/9780190271381.003.0022 · Cited by 142
3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
Young, M. B., Andero, R., Ressler, K. J., & Howell, L. L. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.138 · Cited by 141
A review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy
Sessa, B., Higbed, L., & Nutt, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00138 · Cited by 141 · cited 2×
“…stimuli could mitigate avoidance and defensiveness in therapeutic settings, both reinforcing its relevance as an intervention targeting emotional tolerance and regulation and suggesting that MDMA-AT could help narcissistic individuals to engage with dif fi cult emotions in therapy (151, 153).”
Psychedelic therapy in the treatment of addiction: the past, present and future
Zafar, R. R., Siegel, M., Harding, R., Barba, T., Agnorelli, C., Suseelan, S., Roseman, L., Wall, M. B., Nutt, D. J., & Erritzøe, D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1183740 · Cited by 126 · cited 1×
“…therapy (PAT) when administered in a controlled clinical environment (1, 2) for several treatment-resistant psychiatric disorders including depression (3 – 5), post-traumatic stress disorder (PTSD) (6, 7), substance use disorders (8, 9), social anxiety (10), and obsessive-compulsive disorder (11).”
Slade, A., & Holmes, J. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.06.008 · Cited by 113 · cited 1×
“By processing these relational patterns, within the therapeutic relationship, patients can experience corrective emotional experiences that help shift maladaptive interaction styles toward healthier, more reciprocal ones (166 – 168).”
Psychodynamic Psychotherapy for Personality Disorders: A Clinical Handbook
Fonagy, P., & Gabbard, G. O. (2010) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615376643 · Cited by 113
Psychedelics and psychotherapy: Cognitive-behavioral approaches as default
Yaden, D. B., Earp, D., Graziosi, M., Friedman-Wheeler, D., Luoma, J. B., & Johnson, M. W. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.873279 · Cited by 110 · cited 1×
“Debate continues over which therapeutic modalities best complement psychedelic treatment (110 – 112), with various adapted and ad hoc models being evaluated in clinical research presently (106).”
Carhart-Harris, R. L., Wall, M. B., Erritzoe, D., Kaelen, M., Ferguson, B., De Meer, I., Tanner, M., Bloomfield, M., Williams, T. M., Bolstridge, M., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001405 · Cited by 108
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants
Bershad, A. K., Miller, M. A., Baggott, M. J., & de Wit, H. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116663120 · Cited by 106
Narcissists’ social pain seen only in the brain
Cascio, C. N., Konrath, S. H., & Falk, E. B. (2015) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsu072 · Cited by 104 · cited 2×
“Despite these structural differences, individuals with PN display heightened anterior insula (AI) and dorsal ACC (dACC) activity in response to social exclusion, indicating increased rejection sensitivity despite an outward appearance of emotional detachment (96).”
Effectiveness of targeting the vulnerability factors of depression in cognitive therapy.
Hayes, A. M., Castonguay, L. G., & Goldfried, M. R. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.3.623 · Cited by 102 · cited 1×
“…studies of depression treatments indicate that psychoanalytic psychotherapies emphasizing interpersonal and developmental experiences lead to both short-and long-term improvement, with a developmental focus predicting longer recovery and better functioning over 24 months than other therapies (122).”
Gray matter abnormalities in patients with narcissistic personality disorder
Schulze, L., Dziobek, I., Vater, A., Heekeren, H. R., Bajbouj, M., Renneberg, B., Heuser, I., & Roepke, S. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.017 · Cited by 102
Metacognitive Interpersonal Therapy for Personality Disorders: A treatment manual
Dimaggio, G., Montano, A., Popolo, R., & Salvatore, G. (2015) · Cited by 100
The therapeutic alliance: the fundamental element of psychotherapy
Stubbe, D. E. (2018) · Focus · doi:10.1176/appi.focus.20180022 · Cited by 97 · cited 1×
“The therapeutic alliance is a well-established predictor of positive treatment outcomes across a range of psychotherapeutic modalities (158 – 160), including psychoanalytic psychotherapy (161) and the treatment of personality disorders such as PN (162, 163).”
Sessa, B. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.004 · Cited by 97
MDMA alters emotional processing and facilitates positive social interaction
Wardle, M. C., & de Wit, H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3570-x · Cited by 96 · cited 1×
“Additionally, MDMA enhances positive emotional experiences while blunting negative ones, potentially reducing defensive responses and increasing emotional fl exibility (79, 150).”
Prevalence and treatment of narcissistic personality disorder in the community: a systematic review
Dhawan, N., Kunik, M. E., Oldham, J., & Coverdale, J. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2009.09.003 · Cited by 95 · cited 1×
“Previously regarded as a rare and obscure psychological disorder (43), PN is now recognized as a relatively common personality disorder, with prevalence estimates in the U.S. general population reaching up to 6.2% (44 – 46), with notably higher rates among men (7.7”
InfluentialThe scientific standing of psychoanalysis
Solms, M. (2018) · BJPsych International · doi:10.1192/bji.2017.4 · Cited by 91
Brennan, W., & Belser, A. B. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.866018 · Cited by 90 · cited 15×
“Emerging research supports the safety and ef fi cacy of psychedelic-assisted therapy (PAT) when administered in a controlled clinical environment (1, 2) for several treatment-resistant psychiatric disorders including depression (3 – 5), post-traumatic stress disorder (PTSD) (6, 7), substance use disorders (8, 9), socia…”
InfluentialKuypers, K. P., Dolder, P. C., Ramaekers, J. G., & Liechti, M. E. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699617 · Cited by 89
Perez, N., Langlest, F., Mallet, L., De Pieri, M., Sentissi, O., Thorens, G., Seragnoli, F., Zullino, D., Kirschner, M., Kaiser, S., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.07.011 · Cited by 88
Disturbed emotion recognition in patients with narcissistic personality disorder
Marissen, M. A. E., Deen, M. L., & Franken, I. H. A. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.12.042 · Cited by 87
Acute subjective effects in LSD- and MDMA-assisted psychotherapy
Schmid, Y., Gasser, P., Oehen, P., & Liechti, M. E. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120959604 · Cited by 85
Levin, A. W., Lancelotta, R., Sepeda, N. D., Gukasyan, N., Nayak, S., Wagener, T. L., Barrett, F. S., Griffiths, R. R., & Davis, A. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300501 · Cited by 82
Baggott, M. J., Coyle, J. R., Siegrist, J. D., Garrison, K. J., Galloway, G. P., & Mendelson, J. E. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115626348 · Cited by 79
Current understanding of narcissism and narcissistic personality disorder
Yakeley, J. (2018) · BJPsych Advances · doi:10.1192/bja.2018.20 · Cited by 77 · cited 1×
“This is largely due to stigmatization and limited research focus respectively, with few high-quality population studies and most existing knowledge derived from small sample-size investigations, case reports, and case series (61).”
Countertransference when working with narcissistic personality disorder: An empirical investigation.
Tanzilli, A., Muzi, L., Ronningstam, E., & Lingiardi, V. (2017) · Psychotherapy · doi:10.1037/pst0000111 · Cited by 73 · cited 4×
“Countertransference reactions are prevalent regardless of theoretical orientation (186).”
InfluentialLeuzinger‐Bohleber, M., Kaufhold, J., Kallenbach, L., Negele, A., Ernst, M., Keller, W., Fiedler, M., Hautzinger, M., Bahrke, U., & Beutel, M. E. (2019) · The International Journal of Psychoanalysis · doi:10.1080/00207578.2018.1533377 · Cited by 73
Psychedelics and psychotherapy
Nayak, S., & Johnson, M. W. (2021) · Pharmacopsychiatry · doi:10.1055/a-1312-7297 · Cited by 71
Zeifman, R. J., & Wagner, A. C. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.001 · Cited by 67 · cited 2×
“…exact mechanisms of action remain unclear, and despite study limitations including small sample sizes and challenges in maintaining blindness in placebo-controlled trials (36), these preliminary fi ndings support the potential use of psychedelics in personality disorder treatment (18, 25, 37, 38).”
Earp, B. D. (2018) · Royal Institute of Philosophy Supplement · doi:10.1017/s1358246118000474 · Cited by 67
Can neuroscience help to understand narcissism? A systematic review of an emerging field
Jauk, E., & Kanske, P. (2021) · Personality Neuroscience · doi:10.1017/pen.2021.1 · Cited by 66
Mentalization-Based Treatment for Pathological Narcissism
Drozek, R. P., & Unruh, B. T. (2020) · Journal of Personality Disorders · doi:10.1521/pedi.2020.34.supp.177 · Cited by 64 · cited 1×
“…a few empirically supported treatments originally developed for borderline personality disorder have emerged as adaptations for PN, such as dialectical behavior therapy (DBT) (72), transference-focused psychotherapy (TFP) (73), mentalization-based therapy (MBT) (74, 75), and schema therapy (76).”
MDMA and MDMA-assisted therapy
Wolfgang, A. S., Fonzo, G. A., Gray, J. C., Krystal, J. H., Grzenda, A., Widge, A. S., Kraguljac, N. V., McDonald, W. M., Rodriguez, C. I., & Nemeroff, C. B. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230681 · Cited by 62
Barone, W., Beck, J., Mitsunaga-Whitten, M., & Perl, P. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1580805 · Cited by 61
Psychiatric risks for worsened mental health after psychedelic use
Marrocu, A., Kettner, H., Weiss, B., Zeifman, R. J., Erritzoe, D., & Carhart-Harris, R. L. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241232548 · Cited by 60 · cited 3×
“…naturalistic, uncontrolled study found that individuals with personality disorders were over four times more likely to experience worsened mental health following psychedelic use of psilocybin, lysergic acid diethylamide (LSD)), ayahuasca, N,N-Dimethyltryptamine (DMT)), mescaline, and iboga (17).”
InfluentialNarcissistic Personality Disorder: Progress in Understanding and Treatment
Weinberg, I., & Ronningstam, E. (2022) · Focus · doi:10.1176/appi.focus.20220052 · Cited by 59 · cited 5×
“Patients with PN struggle to access, recognize, and articulate their emotional experiences (60).”
InfluentialMarseille, E., Kahn, J. G., Yazar-Klosinski, B., & Doblin, R. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239997 · Cited by 56 · cited 1×
“Others highlight the scalability and cost-effectiveness of PAT, advocating for research into shorter, more affordable treatment schedules (105).”
Effects of MDMA-assisted therapy for PTSD on self-experience
van der Kolk, B. A., Wang, J. B., Yehuda, R., Bedrosian, L., Coker, A. R., Harrison, C., Mithoefer, M., Yazar-Klosinki, B., Emerson, A., & Doblin, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295926 · Cited by 55
Gao, S., Yu, D., Assink, M., Chan, K. L., Zhang, L., & Meng, X. (2024) · Trauma, Violence, & Abuse · doi:10.1177/15248380221147559 · Cited by 54 · cited 1×
“1 Strongly associated with a history of child maltreatment, particularly neglect (47 – 49), PN is believed to develop in response to early traumatic empathic failures by caregivers who were experienced as “ confusing, unpredictable, and full of hidden agendas ” (50).”
Dos and Don'ts in Treatments of Patients With Narcissistic Personality Disorder
Weinberg, I., & Ronningstam, E. (2020) · Journal of Personality Disorders · doi:10.1521/pedi.2020.34.supp.122 · Cited by 51 · cited 5×
“With a prevalence of up to 20% in clinical populations (59) and high rates of psychiatric comorbidity - including mood, anxiety, substance use disorders, and other personality disorders (60) - PN remains signi fi cantly underdiagnosed and undertreated.”
InfluentialDimaggio, G., & Attinà, G. (2012) · Journal of Clinical Psychology · doi:10.1002/jclp.21896 · Cited by 49
Narcissism and Romantic Relationships
Foster, J. D., & Brunell, A. B. (2018) · Springer eBooks · doi:10.1007/978-3-319-92171-6_34 · Cited by 48 · cited 1×
“The clinical impact of untreated PN extends to the individuals with the condition as well as to those around them - especially their romantic partners and children, who are particularly vulnerable to the transmission of intergenerational trauma (62 – 65).”
Perceived agency mediates the link between the narcissistic subtypes and self-esteem
Brown, A. A., Freis, S. D., Carroll, P. J., & Arkin, R. M. (2016) · Personality and Individual Differences · doi:10.1016/j.paid.2015.10.055 · Cited by 47
Emotion dysregulation acts in the relationship between vulnerable narcissism and suicidal ideation
Ponzoni, S., Beomonte Zobel, S., Rogier, G., & Velotti, P. (2021) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12730 · Cited by 44
Studies with psychedelic drugs in human volunteers
Sellers, E. M., Romach, M. K., & Leiderman, D. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.029 · Cited by 42 · cited 2×
“Moreover, comorbid conditions such as suicidality and substance use disorders further complicate research efforts (13, 18, 20, 21).”
Sauls, D., Zeigler‐Hill, V., Vrabel, J. K., & Lehtman, M. J. (2019) · Personality and Individual Differences · doi:10.1016/j.paid.2019.04.025 · Cited by 38
Zeifman, R. J., Kettner, H., Ross, S., Weiss, B., Mithoefer, M. C., Mithoefer, A. T., & Wagner, A. C. (2024) · European Journal of Psychotraumatology · doi:10.1080/20008066.2023.2297536 · Cited by 37
McIntyre, R. S., Kwan, A. T. H., Mansur, R. B., Oliveira-Maia, A. J., Teopiz, K. M., Maletic, V., Suppes, T. M., Stahl, S. M., & Rosenblat, J. D. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230902 · Cited by 37
Barnett, B. S., Arakelian, M. H., Beebe, D. S., Ontko, J., Riegal, C., Siu, W. O., Weleff, J., & Pope, H. G. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2023.0036 · Cited by 36
Narcissism and risky decisions: a neurophysiological approach
Yang, Z., Sedikides, C., Gu, R., Luo, Y. L. L., Wang, Y., & Cai, H. (2018) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsy053 · Cited by 35
Ronningstam, E. (2020) · Journal of Personality Disorders · doi:10.1521/pedi.2020.34.supp.80 · Cited by 35
Principles of psychodynamic treatment for patients with narcissistic personality disorder
Crisp, H., & Gabbard, G. O. (2020) · Journal of Personality Disorders · doi:10.1521/pedi.2020.34.supp.143 · Cited by 32 · cited 5×
“In psychoanalytic treatment, allowing the patient to take the lead reinforces their ownership of the therapeutic process (71).”
InfluentialGabbard, G. O. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00380-8 · Cited by 32 · cited 7×
“During these crises, symptoms of narcissistic vulnerability are most prominent, including acute suicidality, anhedonic depression, and anxiety (54, 69).”
InfluentialMüller, F., Mühlhauser, M., Holze, F., Lang, U. E., Walter, M., Liechti, M. E., & Borgwardt, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.573953 · Cited by 31
Pagni, B. A., Zeifman, R. J., Mennenga, S. E., Carrithers, B. M., Goldway, N., Bhatt, S., O’Donnell, K. C., Ross, S., & Bogenschutz, M. P. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230887 · Cited by 31
Russell, G. A. (1985) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1985.tb02626.x · Cited by 30 · cited 1×
“The therapeutic alliance is a well-established predictor of positive treatment outcomes across a range of psychotherapeutic modalities (158 – 160), including psychoanalytic psychotherapy (161) and the treatment of personality disorders such as PN (162, 163).”
Schalkwijk, F., Luyten, P., Ingenhoven, T., & Dekker, J. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.676733 · Cited by 30
Mentalization-Based Treatment for a Physician With Borderline Personality Disorder
Drozek, R. P., & Unruh, B. T. (2022) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.20210019 · Cited by 30
Zamaria, J. A., Fernandes-Osterhold, G., Shedler, J., & Yehuda, R. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1505894 · Cited by 29
Kamboj, S. K., Walldén, Y. S. E., Falconer, C. J., Alotaibi, M. R., Blagbrough, I. S., Husbands, S. M., & Freeman, T. P. (2018) · Mindfulness · doi:10.1007/s12671-017-0849-0 · Cited by 28
Psilocybin Without Psychotherapy: A Cart Without a Horse?
Earleywine, M., Leo, J. A. D., Bhayana, D., Rajanna, B., & Scott, K. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230572 · Cited by 28
Calder, A. E., & Hasler, G. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.091 · Cited by 28
Childhood Maltreatment and Narcissism: The Mediating Role of Dissociation
Bertele, N., Talmon, A., & Gross, J. J. (2022) · Journal of Interpersonal Violence · doi:10.1177/0886260520984404 · Cited by 27 · cited 2×
“1 Strongly associated with a history of child maltreatment, particularly neglect (47 – 49), PN is believed to develop in response to early traumatic empathic failures by caregivers who were experienced as “ confusing, unpredictable, and full of hidden agendas ” (50).”
A mentalizing approach for narcissistic personality disorder: Moving from “me-mode” to “we-mode
Choi-Kain, L. W., Simonsen, S., & Euler, S. (2022) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.20210017 · Cited by 26
Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review
Richard, J., & Garcia‐Romeu, A. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00629-8 · Cited by 26 · cited 1×
“…therapy (PAT) when administered in a controlled clinical environment (1, 2) for several treatment-resistant psychiatric disorders including depression (3 – 5), post-traumatic stress disorder (PTSD) (6, 7), substance use disorders (8, 9), social anxiety (10), and obsessive-compulsive disorder (11).”
Okano, L., Jones, G., Deyo, B., Brandenburg, A., & Hale, W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.965641 · Cited by 24
Solaja, I., Haldane, K., Mason, N. L., Weiss, B., Xu, X., Xu, M., Nikolin, S., Jayasena, T., Millard, M., Brett, J., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105570 · Cited by 23
Reed‐Knight, B., & Fischer, S. (2011) · The Handbook of Narcissism and Narcissistic Personality Disorder · doi:10.1002/9781118093108.ch42 · Cited by 23
Ronningstam, E., & Weinberg, I. (2023) · Journal of Personality Disorders · doi:10.1521/pedi.2023.37.3.337 · Cited by 22
Psychedelic-assisted therapy” must not be retired
Deckel, G. M., Lepow, L. A., & Guss, J. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230667 · Cited by 21 · cited 14×
“Emerging research supports the safety and ef fi cacy of psychedelic-assisted therapy (PAT) when administered in a controlled clinical environment (1, 2) for several treatment-resistant psychiatric disorders including depression (3 – 5), post-traumatic stress disorder (PTSD) (6, 7), substance use disorders (8, 9), socia…”
InfluentialZeigler‐Hill, V., Cosby, C. A., Vrabel, J. K., & Southard, A. C. (2020) · Journal of Social and Personal Relationships · doi:10.1177/0265407520939190 · Cited by 21
Recognising Narcissistic Abuse and the Implications for Mental Health Nursing Practice
Howard, V. (2019) · Issues in Mental Health Nursing · doi:10.1080/01612840.2019.1590485 · Cited by 20
Schema Therapy for Narcissism: The Art of Empathic Confrontation, Limit‐Setting, and Leverage
Behary, W. T., & Dieckmann, E. (2011) · The Handbook of Narcissism and Narcissistic Personality Disorder · doi:10.1002/9781118093108.ch40 · Cited by 20
Psychodynamic Psychotherapy for Narcissistic Personality
Diamond, D., Yeomans, F., & Levy, K. N. (2011) · The Handbook of Narcissism and Narcissistic Personality Disorder · doi:10.1002/9781118093108.ch38 · Cited by 19
Stocker, K., & Liechti, M. E. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241265352 · Cited by 19
Do psychedelics facilitate emergence of unconscious psychological processes
Lindegaard, T. (2023) · Psychodynamic Psychiatry · doi:10.1521/pdps.2023.51.3.270 · Cited by 18
Uncovering psychedelics: from neural circuits to therapeutic applications
Melani, A., Bonaso, M., Biso, L., Zucchini, B., Conversano, C., & Scarselli, M. (2025) · Pharmaceuticals · doi:10.3390/ph18010130 · Cited by 17 · cited 2×
“MDMA ’ s ability to enhance global cortical connectivity and neuroplasticity is also believed to play a key role in its therapeutic effects (91).”
What Is Narcissistic Personality Disorder? Lay Theories of Narcissism
Wright, K., & Furnham, A. F. (2014) · Psychology · doi:10.4236/psych.2014.59124 · Cited by 16 · cited 7×
“Before the in-person screening, participants complete a pre-screening survey featuring questions from the Personality Diagnostic Questionnaire-4+ (PDQ-4+) (175), which assesses DSM-5 Section II NPD diagnostic criteria, and the 12-item Super Brief Pathological Narcissism Inventory (SB-PNI) (176), which evaluates narcis…”
InfluentialMDMA-assisted psychotherapy for borderline personality disorder
Traynor, J. M., Roberts, D. E., Ross, S., Zeifman, R., & Choi-Kain, L. (2022) · Focus · doi:10.1176/appi.focus.20220056 · Cited by 15 · cited 1×
“…exact mechanisms of action remain unclear, and despite study limitations including small sample sizes and challenges in maintaining blindness in placebo-controlled trials (36), these preliminary fi ndings support the potential use of psychedelics in personality disorder treatment (18, 25, 37, 38).”
Psilocybin in pharmacotherapy of obsessive-compulsive disorder
Owe-Larsson, M., Kamińska, K., Buchalska, B., Mirowska-Guzel, D. M., & Cudnoch‐Jędrzejewska, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00633-1 · Cited by 15
Weiss, B., Sleep, C., Miller, J. D., & Campbell, W. K. (2023) · Journal of Personality Disorders · doi:10.1521/pedi.2023.37.2.131 · Cited by 15 · cited 1×
“…narcissistic personality traits and antagonistic externalizing behaviors in adults following ayahuasca ceremonies, fi nding modest reductions in entitlement and increases in leadership authority up to three months post-retreat, though effect sizes were small and results mixed across measures (39).”
InfluentialSocial anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol
Lear, M. K., Smith, S. M., Pilecki, B. C., Stauffer, C. S., & Luoma, J. B. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1083354 · Cited by 15 · cited 1×
“…therapy (PAT) when administered in a controlled clinical environment (1, 2) for several treatment-resistant psychiatric disorders including depression (3 – 5), post-traumatic stress disorder (PTSD) (6, 7), substance use disorders (8, 9), social anxiety (10), and obsessive-compulsive disorder (11).”
Gibbons, R. (2023) · BJPsych Advances · doi:10.1192/bja.2023.8 · Cited by 13
Barnett (2024) · doi:10.1089/psymed.2023.0010 · Cited by 13
Hewitt, J. M. A., Kealy, D., Hewitt, P. L., Ko, A., Chen, C., Brugnera, A., Madigan, S. L., & Birch, S. (2024) · Current Psychology · doi:10.1007/s12144-024-05683-5 · Cited by 12
Primum non nocere: The onus to characterize the potential harms of psychedelic treatment
Ghaznavi, S., Ruskin, J. N., Haggerty, S. J., King, F., & Rosenbaum, J. F. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230914 · Cited by 12
Association between pathological narcissism and emotion regulation: The role of self-mentalizing
Blay, M., Bouteloup, M., Duarte, M., Hasler, R., Pham, E., Nicastro, R., Jan, M., Debbané, M., & Perroud, N. (2024) · Personality and Mental Health · doi:10.1002/pmh.1613 · Cited by 10 · cited 3×
“Alexithymia, or dif fi culty identifying, describing, and expressing one ’ s own emotions, is strongly associated with PN, where de fi cits in emotion identi fi cation and metacognition contribute to maladaptive coping and emotional dysregulation (74, 140, 148).”
InfluentialMentalization based treatment for a broad range of personality disorders: a naturalistic study
Rizzi, E., Weijers, J. G., ten Kate, C., & Selten, J. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05865-2 · Cited by 10
Dimaggio, G., & Valentino, V. (2024) · Journal of Clinical Psychology · doi:10.1002/jclp.23621 · Cited by 9
Fang, Q., Chan, V. K. Y., Chan, S. S. M., Jiao, Y., Wang, J., & Li, X. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115960 · Cited by 9
Building hope for treatment of narcissistic personality disorder
Weinberg, I. (2024) · Journal of Clinical Psychology · doi:10.1002/jclp.23598 · Cited by 8 · cited 9×
“Additionally, therapists must work to regulate their own countertransference responses, as therapists can unintentionally collude with maladaptive patterns (e.g., mutual idealization, competitiveness) (70).”
InfluentialBetrayal trauma and personality pathology: an integrated review
Yalch, M. M., & Robbins, A. L. (2025) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2024.2429465 · Cited by 7
Adverse childhood experiences leading to narcissistic personality disorder: a case report
Ross, A. G., Giri, S., Anyasodor, A. E., Mahmood, S., Astawesegn, F. H., Huda, M. M., Ahmed, K. Y., Mondal, U. K., & Thapa, S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06307-9 · Cited by 7
Psychodynamic Approaches to Personality Disorders
Gabbard, G. O. (2005) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.3.3.363 · Cited by 5
Gordon, A. R., Carrithers, B. M., Pagni, B. A., Kettner, H., Marrocu, A., Nayak, S. M., Weiss, B., Carhart-Harris, R. L., Roberts, D. E., & Zeifman, R. J. (2024) · Research Square · doi:10.21203/rs.3.rs-4203641/v1 · Cited by 5
Chapter 7. Transference-Focused Psychotherapy and Borderline Personality Disorder
Yeomans, F. E., & Diamond, D. (2010) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615376643.lg07 · Cited by 5
Dimaggio, G., & Weinberg, I. (2024) · Journal of Clinical Psychology · doi:10.1002/jclp.23652 · Cited by 4
Psychoanalyst attitudes towards psychedelic-assisted therapy
Kraiem, E., Diener, M., Guss, J., Mavrides, L., & Saban, S. (2025) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2024.2359444 · Cited by 4 · cited 1×
“Importantly, there appears to be growing support among psychoanalysts as well as psychiatrists for psychedelic-assisted therapies for their patients (113, 114).”
Pharmacological management of personality disorders: from evidence to practice
Völlm, B., & Cerci, D. (2025) · BJPsych Advances · doi:10.1192/bja.2024.30 · Cited by 4
Could psychedelics treat personality disorders
(2022) · Journal of Addiction Science · doi:10.17756/jas.2022-057 · Cited by 3 · cited 2×
“In spite of these challenges, interest in PAT for personality disorders is increasing (24, 25).”
Mazloumi, F., Pourasghar, M., & Shariatnia, K. (2024) · doi:10.61838/kman.jayps.5.5.11 · Cited by 3
Kramer (2018) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.v25.2 · Cited by 2
Jaksic (2017) · Journal of Clinical Psychology · doi:10.1002/jclp.2017.73.issue-12 · Cited by 2
Effects of psilocybin therapy on personality structure
Erritzoe (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.2018.138.issue-5 · Cited by 2
Smith (2022) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.v62.4 · Cited by 2
MDMA-assisted therapy for borderline personality disorder
Inouye, A. M., Wolfgang, A. S., & Philhower, L. T. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00196 · Cited by 1
Pathological narcissism: An analysis of interpersonal dysfunction within intimate relationships
Day (2022) · Personality and Mental Health · doi:10.1002/pmh.v16.3 · Cited by 1
Alliance building and narcissistic personality disorder
Ronningstam (2012) · Journal of Clinical Psychology · doi:10.1002/jclp.2012.68.issue-8 · Cited by 1
Research works printed but not linked: 11
- Atalay AN. Psychedelic therapy for personality disorders. Psychedelic Support. 2024 Nov 13. Available at: https://psychedelic.support/resources/psychedelic-therapy-for-personality-disorders/ [Accessed February 8, 2025].
- Gasser P. Psycholytic therapy with MDMA and LSD in Switzerland. MAPS Bull. (1995) 5(3): 3– 7. Available from: https://maps.org/news-letters/v05n3/05319gas.html (Accessed February 8, 2025).
- Winnicott DW. Ego distortion in terms of true and false self. In: The maturational processes and the facilitating environment. International Universities Press, New York (1965). p. 140–57.
- Diamond D Yeomans FE Stern BL Kernberg OF. Treating pathological narcissism with transference-focused psychotherapy. New York: Guilford Press (2021).
- Choi-Kain LW Simonsen S Euler S. A mentalizing approach for narcissistic personality disorder: Moving toward integrated treatment. Am J Psychother. (2022) 75: 38– 43. doi: 10.1176/appi.psychotherapy.20210017 35016552 · DOI · Paper page
- Shepherd M. Revisiting the repetition compulsion: Danger and survival in early mental functioning. Mod Psychoanal. (2014) 39(1): 56– 69.
- Frosch J. From grievance to grief: nnarcissism and the inability to mourn. Can J Psychoanal. (2014) 22(2): 259–75.
- Ronningstam E. NPD Basic: A brief overview of identifying, diagnosing, and treating Narcissistic Personality Disorder. 4th ed. Belmont, MA: McLean Hospital, Harvard Medical School (2021).
- Diamond D Yeomans FE Stern BL Kernberg OF. Treating pathological narcissism with transference-focused psychotherapy. New York: The Guilford Press (2022). p. 192.
- First MB Skodol AE Bender DS Oldham JM. Module III: Structured Clinical Interview for Personality Disorders (Including Personality Disorder-Trait Specified). In: First MB Skodol AE Bender DS Oldham JM, editors. Structured Clinical Interview for the DSM-5 Alternative Model for Personality Disorders (SCID-AMPD). American Psychiatric Publishing, Arlington VA (2018).
- Movahed Rad P. Psychedelics could pose risks for people with personality disorders, study finds. Sci Alert 2024 Apr 15. https://www.sciencealert.com/psychedelics-could-pose-risks-for-people-with-personality-disorders-study-finds [Accessed February 8, 2025].
Cited by
Case Report: Amplified psychoanalysis? Psychoanalysis, OCD and MDMA in a clinical case study
Dellanoce, F. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1617428 · Cited by 2
Oceanic states of consciousness—an existential-neuroscience perspective
Unterrainer, H. (2025) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1653801 · Cited by 2
Africanizing Pastoral Psychology for Contextual Practical Ministry: A Holistic Approach
Djabanor, J., & Ayete-Nyampong, S. (2025) · E-Journal of Religious and Theological Studies · doi:10.38159/erats.202511125
Fischman, L. G. (2026) · Psychedelics · doi:10.1016/j.psyche.2026.100013
Molecular Modeling of the Pathogenetic Mechanisms of Neuropsychiatric Disorders
Abdurazakov, A., Abashkin, D. A., Semina, E. V., Chaika, Y. A., & Golimbet, V. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083563 · Cited by 2
Metadata
- Authors
- Albert, A. E., & Back, A. L.
- Affiliations
- University of Washington (US)
- Corresponding author
- Albert, Alexa E.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2025-04-02
- Volume
- 16
- Pages
- 1529427-1529427
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC12006724
- OpenAlex
- W4409083076
- Cited by
- 6
- References
- 183
- Citations by year
- 2026: 4 · 2025: 2
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Keywords
- pathological narcissism, MDMA-assisted psychotherapy, psychedelic-assisted psychotherapy, psychoanalytic psychotherapy, early relational trauma, attachment trauma, therapeutic relationship, mechanisms of change, empathy, self-esteem, personality disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
